1. Academic Validation
  2. HIV-1-induced type I IFNs promote viral latency in macrophages

HIV-1-induced type I IFNs promote viral latency in macrophages

  • J Leukoc Biol. 2022 May 19. doi: 10.1002/JLB.4MA0422-616R.
Laura L Dickey 1 Laura J Martins 1 Vicente Planelles 1 Timothy M Hanley 1
Affiliations

Affiliation

  • 1 Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Abstract

Macrophages chronically infected with HIV-1 serve as a reservoir that contributes to HIV-1 persistence during antiretroviral therapy; however, the mechanisms governing the establishment and maintenance of this virus reservoir have not been fully elucidated. Here, we show that HIV-1 enters a state reminiscent of latency in monocyte-derived macrophages (MDMs), characterized by integrated proviral DNA with decreased viral transcription. This quiescent state is associated with decreased NF-κB p65, RNA polymerase II, and p-TEFb recruitment to the HIV-1 promoter as well as maintenance of promoter chromatin in a transcriptionally nonpermissive state. MDM transition to viral latency is mediated by type I IFN signaling, as inhibiting type I IFN signaling or blocking type 1 IFN prevents the establishment of latent Infection. Knockdown studies demonstrate that the innate immune signaling molecule mitochondrial Antiviral signaling protein (MAVS) is required for the transition to latency. Finally, we demonstrate a role for the viral accessory protein Vpr in the establishment of HIV-1 latency in macrophages. Our data indicate that HIV-1-induced type I IFN production is responsible for the establishment of viral latency in MDMs and identify possible therapeutic targets for the prevention or elimination of this important HIV-1 reservoir.

Keywords

HIV-1; IFN; MAVS; NF-κB; latency; macrophage.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》